— Know what they know.
Not Investment Advice
Also trades as: IVA (NASDAQ) · $vol 5M · IVA.PA (PAR) · $vol 2M · 0RNK.L (LSE) · $vol 0M

IVEVF OTC

Inventiva S.A.
1W: -10.3% 1M: -10.3% 3M: -10.3% YTD: -27.5% 1Y: +41.2% 3Y: -13.7% 5Y: -70.7%
$3.22
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 37 · $760.6M mcap · 158M float · 0.0000% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$15M -15.8% ▼
5Y CAGR: +16.0%
Gross Profit
$9M -47.4% ▼
5Y CAGR: +5.6%
Operating Income
-$98M +5.0% ▲
Net Income
-$184M -66.8% ▼
EPS (Diluted)
$-3.08 -26.7% ▼
EBITDA
-$97M +5.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$372K$4M$12M$17M$15M
YoY Growth-94.7%+1027.4%+190.4%+43.5%-15.8%
Cost of Revenue$846K$1M$995K-$23K$6M
Gross Profit-$474K$3M$11M$18M$9M
Gross Margin-127.4%75.8%91.8%100.1%62.5%
R&D Expenses$24M$48M$60M$110M$91M
SG&A Expenses$9M$12M$15M$16M$17M
Operating Expenses$30M$56M$69M$120M$107M
Operating Income-$30M-$52M-$57M-$103M-$98M
Operating Margin-7988.7%-1242.6%-468.9%-587.7%-662.6%
Interest Expense$66K$142K$755K$5M$12M
Income Before Tax-$34M-$49M-$54M-$110M-$184M
Tax Expense-$2M$364K-$20K$607K$313K
Net Income-$32M-$50M-$54M-$110M-$184M
Net Margin-8500.8%-1183.5%-445.6%-631.8%-1251.1%
EPS (Diluted)$-0.93$-1.27$-1.31$-2.43$-3.08
EBITDA-$33M-$52M-$52M-$102M-$97M
Shares Outstanding34M39M41M45M60M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms